Stefano Molica

61PUBLICATIONS
62CO-AUTHORS
Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (61)

|Aug 05, 2026
Navigating the Paradigm Shift in Chronic Lymphocytic Leukemia: Insights From EHA 2026.

|Jul 24, 2026
Surrogate Endpoints in CLL: From Promise and Pitfalls to a Context-Specific Validation Framework.

|Jul 12, 2026
Polypharmacy in Chronic Lymphocytic Leukemia in the Era of Targeted Agents: A Medication Stewardship Perspective.

|Jul 03, 2026
Embedding cardiovascular risk assessment into routine BTK inhibitor management in chronic lymphocytic leukemia.

|May 08, 2026
Cardiovascular Safety Across Leading BTK Inhibitors in Relapsed/Refractory CLL: Results of a Network Meta-Analysis.

|Apr 13, 2026
Bridging Trials and Real Life in Fixed-Duration BTKi-Venetoclax for CLL: A Delphi-Enhanced Synthesis Incorporating Artificial Intelligence (AI) Benchmarks.

Stefano Molica, Mariano Lucignano, Maria Rosaria Villa

Pageof 11

Frequent Collaborators

11 joint publications

David Allsup

9 joint publications

Francesca Romana Mauro

8 joint publications

Luca Laurenti

5 joint publications

Gian Matteo Rigolin